Decline in the prevalence of pandemic clones Spain23F-1 and Spain9V-3 among US fluoroquinolone-resistant Streptococcus pneumoniae TRUST surveillance isolates since 2001

Postgraduate Medicine

Volumn 120, Issue 3, 2008, Pages 39-46

  Davies, Todd A ^a   Yee, Y Cheung ^b   Goldschmidt, Raul ^a   Sahm, Daniel F ^c   Evangelista, Alan T ^b  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

^c Eurofins Medinet Inc   (Germany)

Author keywords

Levofloxacin; Pneumococci; Spain23f 1; Streptococcus pneumoniae

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLINDAMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; OFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLONAL VARIATION; CLONE; HEALTH SURVEY; MUTATION; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; CELL CLONE; EPIDEMIC; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PREVALENCE; STREPTOCOCCUS INFECTION;

CLONE CELLS; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; PREVALENCE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 66849093340     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2008.09.suppl52.283     Document Type: Article

References (31)

1. Corso A, Severma EP, Petruk VF, Mauriz YR, Tomasz A. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States. Microb Drug Resist. 1998;4(4):325-337. (Pubitemid 29180104)
2. Klugman KP. The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae. J Antimicrob Chemother. 2002;50(suppl 2):1-5.
3. Richter SS, Heilmann KP, Coffman SL, et al. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. Clin Infect Dis. 2002;34(3):330-339.
4. Pneumococcal Molecular Epidemiology Network. Clone collection. http://www.sph.emory.edu/PMEN/pmcn-clone-collection.html. Accessed January 25, 2007.
5. McGee L, McDougal L, Zhou J, et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol. 2001;39(7):2565-2571. (Pubitemid 32606233)
6. McGee L, Padayachee T, Goldsmith C, et al. Development of fluoroquinolone resistance among pandemic clones of multidrug-resistant S pneumoniae: retained activity of gemifloxacin. Presented at: 39th Interscience Conference in Antimicrobial Agents and Chemotherapy; September 26-29, 1999; San Francisco, CA.
7. Alou L, Ramirez M, Garcia-Rey C, Prieto J, de Lencastre H. Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resisiant epidemic clones. Antimicrob Agents Chemother. 2001;45(10):2955-2957. (Pubitemid 32906703)
8. Brown SD, Farrell DJ, Morrissey I. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study. J Clin Microbiol. 2004;42(11):4980-4987.
9. Davies TA, Goldschmidt R, Pfleger S, et al. Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000). J Antimicrob Chemother. 2003;52(2):168-175.
10. de la Campa AG, Balsalobre L, Ardanuy C, Fenoll A, Pérez-Trallero E, Liñares J. Spanish Pneumococcal Infection Study Network G03/103. Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain. Emerg Infect Dis. 2004;10(10):1751-1759.
11. Ho PL, Yam WC, Cheung TK, et al. Fluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F clone. Emerg Infect Dis. 2001;7(5):906-908. (Pubitemid 33121605)
12. McGee L, Goldsmith CK, Klugman KP. Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones. J Antimicrob Chemother. 2002;49(1):173-176. (Pubitemid 34100663)
13. Pletz MW, McGee L, Jorgensen J, et al. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother. 2004;48(9):3491-3497. (Pubitemid 39129350)
14. Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Rice CL, Doern GV. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations. Clin Infect Dis. 2005;40(2):225-235. (Pubitemid 40110665)
15. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. 7th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2006:1-49.
16. Lefevre JC, Faucon G, Sicard AM, Gase AM. DNA fingerprinting of Streptococcus pneumoniae strains by pulsed-field gel electrophoresis. J Clin Microbiol. 1993;31(10):2724-2728. (Pubitemid 23284911)
17. Tenover FC, Arbeit RD, Gocring RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233-2239.
18. Pan XS, Ambler J, Mehtar S, Fisher LM. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996;40(10):2321-2326. (Pubitemid 26328040)
19. Ho PL, Yung RW, Tsang DN, et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother. 2001;48(5):659-665.
20. Ho PL, Que TL, Chiu SS, et al. Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001. Emerg Infect Dis. 2004;10(7):1250-1257.
21. Morrissey I, Farrell DJ, Bakker S, et al. Molecular characterization and antimicrobial susceptibility of fluoroquinolone-resistant or -susceptible Streptococcus pneumoniae from Hong Kong. Antimicrob Agents Chemother. 2003;47(4):1433-1435. (Pubitemid 36368613)
22. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility at Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med. 1999;341(4):233-239.
23. Nichol KA, Zhanel GG, Hoban DJ. Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in Canada. Antimicrob Agents Chemother. 2003;47(2):804-808. (Pubitemid 36158120)
24. Yokota S, Sato K, Kuwahara O, et al. Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan. Antimicrob Agents Chemother. 2002;46(10):3311-3315. (Pubitemid 35052651)
25. Morosini MI, Loza E, del Campo R, Almaraz F, Baquero F, Cantón R. Fluoroquinolone-resistant Streptococcus pneumoniae in Spain: activities of garenoxacin against clinical isolates including strains with altered topoisomerases. Antimicrob Agents Chemother. 2003;47(8):2692-2695. (Pubitemid 36919484)
26. Hsueh PR, Teng LJ, Wu TL, et al. SMART Program 2001 Data. Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data. Antimicrob Agents Chemother. 2003;47(7):2145-2151.
27. Johnson CN, Benjamin JW Jr, Moser SA, et al. Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America. J Clin Microbiol. 2003;41(6):2458-2464. (Pubitemid 36712452)
28. Gherardi G, Whitney CG, Facklam RR, Beall B. Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis. 2000:181(1):216-229. (Pubitemid 30049052)
29. Ghaffar F, Barton T, Lozano J, et al. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin Infect Dis. 2004;39(7):930-938. (Pubitemid 39313446)
30. Talbot TR, Poehling KA, Hartert TV, et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2004;39(5):641-648. (Pubitemid 39180434)
31. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet. 2003;361(9376):2189- 2195. (Pubitemid 36782552)